Technology Licensing opportunities

Available technologies

Clear search
Deep learning cardiac motion analysis for risk stratification of adverse cardiac event

A tool for predicting risk profile in patients with pre-existing cardiac dysfunction with greater accuracy than the current gold standard

Bio-Surfactant: a novel biobased surfactant

A surfactant produced from biobased chemicals that can replace petroleum-derived detergents, exhibiting higher performances in cleaning and resistance to hard water.

Methods to scale production of hPSC-derived endothelial cells

A novel 3D culture methodology using stirred-tank bioreactors as a scalable platform for the production of hPSC-derived endothelial cells.

ArterioWave - simple ultrasound-based diagnosis and monitoring of heart failure

ArterioWave is a novel ultrasound-based tool for screening and monitoring those at risk of, or suffering from, heart failure. It can be used by non-specialists and can be implemented on ultrafast or conventional scanners or handheld devices.

A cytokine for wound healing and scar reduction

A cytokine that promotes wound healing by accelerating re-epithelialization of the wound bed faster than FDA approved products. The treatment also has a potential to minimise scarring after injury

Active delivery of Zinc Fingers for in vivo enhancement of gene regulation

A universal method to enhance control of gene expression in vivo with artificial gene-regulatory transcription factors.

Zinc finger therapy for Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)

New zinc finger peptides and encoding nucleic acid molecules that can be used for the modulation of gene expression; this has therapeutic applications for neuro-degenerative disorders like FXTAS where altered expression of genes is part of the disease aetiology.

Zinc finger therapy for Amyotrophic lateral sclerosis (ALS) and Frontotemporal dementia (FTD)

New zinc finger peptides and encoding nucleic acid molecules that can be used for the modulation of gene expression in vitro and/or in vivo. This invention has therapeutic applications for neurological disorders such as ALS and FTD where altered expression of genes is part of the disease aetiology.

Charcot-Marie Tooth Disease model

Model for Charcot-Marie Tooth Disease

MicroRNA Biomarkers for ectopic or intrauterine pregnancy

MicroRNA are important gene regulators and their expression profiles change with pathophysiology, allowing their use as biomarkers. Imperial researchers have identified differential markers that can distinguish pregnancy of unknown location (PUL).

Subscribe for Licensing Opportunities updates
Keep up to date with new technologies and licensing opportunities coming out of Imperial College London